CBA Florida Inc. (fka CBAI)

[worthylion]

China Cord Blood is in the middle of a going private transaction from it founder/CEO so I doubt they would add a CBAI transaction into the mix. In any case, I don't think CBAI will be valued by potential buyer as a vibrant ongoing concern given its declining operating results and lack of leadership/management. I'm guessing (just a guess) that Q4 results due at the end of March aren't going to impress. Bottom line is that the company's sale price will be driven by the value its $2.5 million in recurring revenues net of its debt, golden parachutes and other expenses associated with its legacy operations. If a buyer wants to maintain the office/freezer in LV then the annual lease and staffing cost of doing that will be factored into the valuation (netted from recurring revenues). The big question is what multiple a buyer will pay for the net recurring revenue.